Overview
- 2 FDA inspections are on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2024-11-01.
At a glance
Inspections
2
Form 483s
1
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 28 Oct 2024 – 1 Nov 2024 | Biologics | 483 | View 483 → |
| 28 Feb 2022 – 4 Mar 2022 | Biologics | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
1 Nov 2024
21 CFR 600.80(c)(1)(i)
Reporting Requirements - 15-day alert
Cited by Peng Zhou, Richard L Bartlett, Lizaida Perez
Investigators
FDA investigators tied to this site in the record.
Peng Zhou1 insp.
Richard L Bartlett1 insp.
Lizaida Perez1 insp.
Zhongren Wu1 insp.
Donald B Ertel1 insp.
Graeme E Price1 insp.
Phillip C Thai1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 600.80(c)(1)(i) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Kite Pharma, Inc.'s 1 Form 483
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat